跳至主要内容
临床试验/NCT05572502
NCT05572502招募中不适用

The Feasibility, Implementation and Efficacy of a Diabetes Reversal Online Program and Study (DROP Study) in an Office Setting

Physicians Committee for Responsible Medicine2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
2
主要终点
Glycated hemoglobin

研究概览

简要总结

This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels, body weight, and cholesterol levels.

详细描述

This study aims to assess the feasibility and implementation of an online, plant-based, diabetes reversal program in a community setting. The study will also assess changes in glycated hemoglobin, body weight, and plasma lipids with an online 12-week, plant-based, nutrition education program. These health benefits may illustrate feasibility to physicians and healthcare professionals elsewhere, in addition to their value for the individual research participants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • U.S. Men and women meeting the age of majority, defined as follows: Age 19 or older in Nebraska and Alabama; Age 21 or older in Mississippi; Age 18 or older in all other states
  • Prior diagnosis of type 2 diabetes mellitus

排除标准

  • Use of recreational drugs in the past 6 months
  • Pregnancy or intention to become pregnant during the study period, as verified by self-report
  • Unstable medical or psychiatric illness
  • Lack of English fluency
  • Inability to maintain current medication regimen
  • Inability or unwillingness to participate in all components of the study

结局指标

主要结局

Glycated hemoglobin

时间窗: 12 weeks

A1c will be measured before and after the study period

次要结局

  • body weight(12 weeks)
  • total cholesterol(12 weeks)
  • LDL cholesterol(12 weeks)
  • medication usage(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vanita Rahman

Clinic Director

Physicians Committee for Responsible Medicine

研究点 (2)

Loading locations...

相似试验